CytoSPAR
Plano, US · Founded 2021 · Delaware corporation
Find your way into CytoSPAR
Sign up to find every way you can get introduced to CytoSPAR
- Your email: who you already know at CytoSPAR, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the CytoSPAR team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
MA
Mark AllenNamed on SEC filing
RW
Russell WilliamsNamed on SEC filing
WW
William WeismanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2022
▶$2MraisedMay 2022 · 6 investors · Other TechnologyRule 506(b)
▶$2MraisedMay 2022 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark AllenDirector
- Russell WilliamsExecutive Officer, Director
- William WeismanDirector
- Offering amount
- $5M
- Amount sold
- $2M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CytoSPAR raised?
- CytoSPAR has disclosed $2M raised across 1 round.
- Where is CytoSPAR headquartered?
- CytoSPAR is headquartered in Plano, US.